Aripiprazole augmentation is a research area focused on the use of the medication aripiprazole in combination with other psychiatric medications to enhance the effectiveness of treatment for various mental health conditions. Aripiprazole is an atypical antipsychotic medication commonly used to treat schizophrenia, bipolar disorder, and major depressive disorder. Augmentation refers to the strategy of adding aripiprazole to an existing treatment regimen in order to improve outcomes or manage symptoms that have not fully responded to initial treatment. Research in this area explores the potential benefits, risks, and optimal dosages of aripiprazole augmentation in different populations and for various mental health disorders.